A nurse gives a boy a Pfizer-BioNTech coronavirus shot at a vaccine clinic at Lyman High School in Longwood, Fla., on the day before classes began for the 2021-22 school year. (Paul Hennessy/SOPA Images/LightRocket/Getty Images)

An independent panel of vaccine experts said Tuesday that the Food and Drug Administration should grant emergency authorization to administer the Pfizer-BioNTech coronavirus vaccine to children 5 to 11 years old.

The decision comes amid a nationwide effort to make vaccines available to this group of 28 million children by the first week of November, according to the Biden administration.

White House officials said they have already acquired enough doses to vaccinate every child in that age group.